1. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies
   Iris Lodewijk et al, 2023, Frontiers in Immunology CrossRef
2. Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance
   K A Whelan et al, 2017, Oncogene CrossRef
3. Modulation of CD44, EGFR and RAC Pathway Genes (WAVE Complex) in Epithelial Cancers
   Pranathi Tata et al, 2019, Current Pharmaceutical Design CrossRef
4. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma
   Reihaneh Alsadat Mahmoudian et al, 2021, Molecular and Cellular Biochemistry CrossRef
5. Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
   Anja Mortensen et al, 2018, International Journal of Oncology CrossRef
6. High Throughput Identification of Monoclonal Antibodies to Membrane Bound and Secreted Proteins Using Yeast and Phage Display
   Lequn Zhao et al, 2014, PLoS ONE CrossRef